"this could be the next MSB" looking at msb charts over last 10 years, that's hardly a compliment. looking further back at MSB charts from 2005 to 2011, the gains from $0.45 to $8.90 were 20x. idk how potential market size compares with this type of product.
from asx 02/11/2021 (p2) "Global sales for approved MS drugs in 2020 was approximately US$22B"
I like the stock, the '100 bagger' headline is over enthusiastic. (but hey, let that enthusiasm flow)
I'm coming to terms with the medical trials (not my area of strength), I'm seeing studies using 'cell-based models' and the commencement of 13-week ocular toxicity study in non-human primates (due for completion end of January 2021(assuming this started 1st September)
NSB Price at posting:
34.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)